Availability of services for the diagnosis and treatment of infertility in The Gambia`s public and private health facilities: a cross-sectional survey.


Journal

BMC health services research
ISSN: 1472-6963
Titre abrégé: BMC Health Serv Res
Pays: England
ID NLM: 101088677

Informations de publication

Date de publication:
07 Sep 2022
Historique:
received: 09 05 2022
accepted: 31 08 2022
entrez: 7 9 2022
pubmed: 8 9 2022
medline: 11 9 2022
Statut: epublish

Résumé

Infertility is a long-standing reproductive health issue, which affects both men and women worldwide and it is especially problematic in the Global South. In sub-Saharan Africa, understanding the current availability of diagnostic and treatment services for infertility is important because this could guide health systems to improve access to fertility care for all. Yet, few studies have explicitly started from a health system perspective to grasp the availability and integration of infertility services in sub-Saharan Africa. This quantitative study, the first in The Gambia, West Africa, examines the availability of infertility services in public and private facilities as part of a wider endeavour to improve fertility care policy and practice in the country. A cross-sectional survey using Qualtrics was administered to 38 health facilities. The survey was carried out between March and August 2021 and involved closed-ended questions. Data analysis consisted of descriptive statistics and t-tests performed using SPSS version 26. A total of 25 facilities (66%) offered infertility services, of which 13 (52%) were public and 12 (47%) private. Although the availability of screening tests was similar between health institutions, most diagnostic and treatment services were available only in the private sector. Treatment services included: (i) ovarian stimulation (n = 16, 42%); (ii) reversal of tubal ligation and/or blockage (tuboplasty) (n = 4, 11%); and (iii) intrauterine insemination (n = 3, 8%). Assisted reproductive technologies such as IVF and ICSI were not available in public or private sectors. The Gambian health management information system lacked a dedicated space to capture data on infertility. Reported barriers to integration of infertility services in existing reproductive health services included a lack of specialised training, an absence of national guidance on infertility management, and a shortage of appropriate equipment, supplies, and medication. The availability of infertility services in The Gambia follows a trajectory that is similar to other SSA countries in which services are mostly obtainable through the private sector. Yet, access to private care is expensive and geographically restricted, which exacerbates inequalities in accessing fertility care for all. Improving the provision of infertility services in the public sector requires systematically capturing data on infertility and investing in the provision of a full-range fertility care package.

Sections du résumé

BACKGROUND BACKGROUND
Infertility is a long-standing reproductive health issue, which affects both men and women worldwide and it is especially problematic in the Global South. In sub-Saharan Africa, understanding the current availability of diagnostic and treatment services for infertility is important because this could guide health systems to improve access to fertility care for all. Yet, few studies have explicitly started from a health system perspective to grasp the availability and integration of infertility services in sub-Saharan Africa. This quantitative study, the first in The Gambia, West Africa, examines the availability of infertility services in public and private facilities as part of a wider endeavour to improve fertility care policy and practice in the country.
METHODS METHODS
A cross-sectional survey using Qualtrics was administered to 38 health facilities. The survey was carried out between March and August 2021 and involved closed-ended questions. Data analysis consisted of descriptive statistics and t-tests performed using SPSS version 26.
RESULTS RESULTS
A total of 25 facilities (66%) offered infertility services, of which 13 (52%) were public and 12 (47%) private. Although the availability of screening tests was similar between health institutions, most diagnostic and treatment services were available only in the private sector. Treatment services included: (i) ovarian stimulation (n = 16, 42%); (ii) reversal of tubal ligation and/or blockage (tuboplasty) (n = 4, 11%); and (iii) intrauterine insemination (n = 3, 8%). Assisted reproductive technologies such as IVF and ICSI were not available in public or private sectors. The Gambian health management information system lacked a dedicated space to capture data on infertility. Reported barriers to integration of infertility services in existing reproductive health services included a lack of specialised training, an absence of national guidance on infertility management, and a shortage of appropriate equipment, supplies, and medication.
CONCLUSIONS CONCLUSIONS
The availability of infertility services in The Gambia follows a trajectory that is similar to other SSA countries in which services are mostly obtainable through the private sector. Yet, access to private care is expensive and geographically restricted, which exacerbates inequalities in accessing fertility care for all. Improving the provision of infertility services in the public sector requires systematically capturing data on infertility and investing in the provision of a full-range fertility care package.

Identifiants

pubmed: 36071443
doi: 10.1186/s12913-022-08514-0
pii: 10.1186/s12913-022-08514-0
pmc: PMC9450453
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1127

Subventions

Organisme : Research England GCRF - Quality Related Sustainable Partnership Award
ID : 161059
Organisme : Research England GCRF - Quality Related Sustainable Partnership Award
ID : 161059

Informations de copyright

© 2022. The Author(s).

Références

Ann Afr Med. 2011 Jan-Mar;10(1):19-24
pubmed: 21311150
Malar J. 2018 Nov 15;17(1):425
pubmed: 30442132
Pan Afr Med J. 2021 Nov 30;40:191
pubmed: 35096218
Soc Sci Med. 1998 Apr;46(7):891-9
pubmed: 9541074
Hum Reprod. 2013 Oct;28(10):2755-64
pubmed: 23878180
Hum Reprod. 2010 Aug;25(8):2024-30
pubmed: 20573675
Hum Reprod Update. 2008 Nov-Dec;14(6):605-21
pubmed: 18820005
Hum Reprod. 2007 Jun;22(6):1506-12
pubmed: 17376819
Ethn Health. 2016 Aug;21(4):357-74
pubmed: 26778613
PLoS One. 2019 Jan 31;14(1):e0211634
pubmed: 30703136
Hum Reprod Update. 2022 Feb 28;28(2):190-199
pubmed: 34888683
Hum Reprod Update. 2021 Feb 19;27(2):213-228
pubmed: 33238297
Hum Reprod. 2008 Feb;23(2):352-7
pubmed: 18063652
Cochrane Database Syst Rev. 2015 Mar 22;(3):CD009517
pubmed: 25803542
Fertil Steril. 2017 Sep;108(3):393-406
pubmed: 28760517
PLoS One. 2021 Dec 9;16(12):e0260346
pubmed: 34882706
Forum Health Econ Policy. 2015 Jan 1;18(1):65-74
pubmed: 31419883
Patient Educ Couns. 1997 May;31(1):29-37
pubmed: 9197800
Health Policy Plan. 2009 Mar;24(2):108-15
pubmed: 19181675
Cult Health Sex. 2022 Feb;24(2):268-283
pubmed: 33135970
PLoS Med. 2012;9(12):e1001356
pubmed: 23271957
Fertil Steril. 2009 Aug;92(2):413-6
pubmed: 19324335
Reprod Biomed Soc Online. 2016 Oct 05;2:108-115
pubmed: 29892723
J Obstet Gynaecol Res. 2013 Mar;39(3):680-4
pubmed: 23106834
Fertil Steril. 2002 May;77(5):873-82
pubmed: 12009338
Afr J Reprod Health. 2019 Mar;23(1):111-116
pubmed: 31034177
PLoS One. 2021 Nov 29;16(11):e0260084
pubmed: 34843498
Reprod Health. 2019 Jul 15;16(1):103
pubmed: 31307488
Am J Trop Med Hyg. 2021 Jan 25;104(3):812-813
pubmed: 33534749
PLoS One. 2019 Dec 4;14(12):e0226079
pubmed: 31800633
Reprod Biol Endocrinol. 2015 Apr 26;13:37
pubmed: 25928197
J Gynecol Obstet Hum Reprod. 2020 Jun;49(6):101743
pubmed: 32272168
Reprod Biomed Soc Online. 2016 Jun 21;2:32-38
pubmed: 29892714
Hum Fertil (Camb). 2020 Jul 7;:1-8
pubmed: 32635774
Glob Public Health. 2014;9(8):894-909
pubmed: 25203251
J R Soc Med. 2014 Apr 16;107(1 suppl):28-33
pubmed: 24739381
Reprod Health. 2018 Sep 12;15(1):151
pubmed: 30208896
Soc Sci Med. 2003 May;56(9):1837-51
pubmed: 12650724
Facts Views Vis Obgyn. 2012;4(2):102-9
pubmed: 24753897
Hum Reprod. 2002 May;17(5):1288-91
pubmed: 11980753
Hum Reprod. 2016 Jun;31(6):1241-4
pubmed: 27008891
Hum Reprod. 2017 May 1;32(5):1064-1074
pubmed: 28204493
Hum Reprod. 2002 Jun;17(6):1663-8
pubmed: 12042295
Hum Reprod Open. 2018 Mar 26;2018(2):hoy003
pubmed: 30895245
Fertil Res Pract. 2020 Dec 2;6(1):20
pubmed: 33292584
J Hum Reprod Sci. 2015 Oct-Dec;8(4):191-6
pubmed: 26752853
Facts Views Vis Obgyn. 2017 Mar;9(1):39-44
pubmed: 28721183
Actas Urol Esp (Engl Ed). 2020 Jun;44(5):321-327
pubmed: 32241672
Hum Reprod. 2016 Sep;31(9):2108-18
pubmed: 27365525

Auteurs

Anna Afferri (A)

School of Health and Related Research - ScHARR, The University of Sheffield, Sheffield, UK. aafferri1@sheffield.ac.uk.

Haddijatou Allen (H)

Medical Research Council - MRC The Gambia Unit, Fajara, The Gambia.

Susan Dierickx (S)

Research Centre Gender, Diversity and Intersectionality - RHEA, Vrije Universiteit Brussel, Ixelles, Belgium.

Mustapha Bittaye (M)

The Gambia Ministry of Health, Banjul, The Gambia.
School of Medicine and Allied Health Sciences, University of The Gambia, Banjul, The Gambia.

Musa Marena (M)

The Gambia Ministry of Health, Banjul, The Gambia.
School of Medicine and Allied Health Sciences, University of The Gambia, Banjul, The Gambia.

Allan Pacey (A)

Department of Oncology and Metabolism, The Medical School, The University of Sheffield, Sheffield, UK.

Julie Balen (J)

School of Health and Related Research - ScHARR, The University of Sheffield, Sheffield, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH